Embecta (NASDAQ:EMBC - Get Free Report) is scheduled to release its earnings data before the market opens on Tuesday, November 26th. Analysts expect Embecta to post earnings of $0.40 per share for the quarter. Individual interested in listening to the company's earnings conference call can do so using this link.
Embecta Price Performance
Shares of NASDAQ EMBC traded down $0.94 during mid-day trading on Tuesday, reaching $13.48. 356,983 shares of the company's stock were exchanged, compared to its average volume of 400,993. Embecta has a 52 week low of $9.93 and a 52 week high of $19.79. The firm has a 50-day moving average price of $14.55 and a two-hundred day moving average price of $13.91. The firm has a market capitalization of $777.80 million, a price-to-earnings ratio of 12.02 and a beta of 0.97.
Embecta Company Profile
(
Get Free Report)
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Featured Articles
Before you consider Embecta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Embecta wasn't on the list.
While Embecta currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
